Financial News
Latest News about NVO
Recent news which mentions NVO
Cautious Investor? 2 Safe Stocks You Also Can Count on For Growth
November 11, 2023
From Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
November 10, 2023
From Benzinga
From MarketWatch
3 Stocks to Buy for Retirees Looking to Beat Inflation
November 10, 2023
From InvestorPlace
Who’s afraid of Ozempic? From restaurants to package makers, companies work to calm investors’ GLP-1 jitters.
November 10, 2023
From MarketWatch
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
November 10, 2023
From Benzinga
Novo Nordisk, maker of Ozempic and Wegovy, to invest more than $6 billion to expand production
November 10, 2023
From MarketWatch
Widely Popular GLP-1-Based Weight Loss Drugs Reshape US Healthcare Landscape, May Help Control Addiction
November 10, 2023
From Benzinga
'I Want You To Buy It, And Every Time It Dips, I Want You To Buy More': Cramer Hypes Up Auto Parts Retailer
November 10, 2023
From Benzinga
Could Novo Nordisk Stock Help You Retire a Millionaire?
November 10, 2023
Tickers
NVO
From Motley Fool
Novo Nordisk Seeks Obesity, Diabetes 'Bolt-On' Deals As It Beefs Up Capacity To Meet Soaring Demand
November 10, 2023
Tickers
NVO
From Benzinga
7 Biotech Stocks to Buy for Big-Time Gains
November 10, 2023
From InvestorPlace
From Motley Fool
From Motley Fool
Lilly's Strategic Branding Move For Weight Loss Drug Sets Stage For Long Term Success - Analyst
November 09, 2023
From Benzinga
From Motley Fool
Novo Nordisk Ceases Production Of One Long-Acting Insulin In US Amid Manufacturing Constraints, Competition
November 09, 2023
Tickers
NVO
From Benzinga
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
November 09, 2023
Tickers
NVO
From Motley Fool
Weight Loss Drug Competition - FDA Approves Expanded Use Of Eli Lilly's Blockbuster Tirzepatide For Weight Loss, Undercutting Novo Nordisk's Price
November 08, 2023
From Benzinga
Eli Lilly gets FDA approval for new obesity drug
November 08, 2023
From MarketWatch
10 Health Care Stocks Whale Activity In Today's Session
November 08, 2023
From Benzinga
Eli Lilly chief scientific officer ‘extremely optimistic’ that major new Alzheimer’s breakthrough is coming
November 06, 2023
From MarketWatch
European Pharma Rules Overhaul, Concerns Arise Over Billions In Lost Investment, Undiscovered Treatments
November 06, 2023
Tickers
NVO
From Benzinga
Why Novo Nordisk Stock Flopped on Friday
November 03, 2023
From Motley Fool
Fed Holds Rates Steady, Powell's Cautious Stance Soothes Investors, Labor Market Softens: The Week In The Markets
November 03, 2023
From Benzinga
Insulet shares rebound after results top estimates
November 03, 2023
From MarketWatch
Ozempic Sales Soar 56% in Q3. But Is Eli Lilly a Better Stock to Buy Than Novo Nordisk?
November 03, 2023
From Motley Fool
1 Stock-Split Stock to Buy Hand Over Fist in November, and 1 to Avoid
November 03, 2023
From Motley Fool
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.